Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 1

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 1

Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1Подробнее

Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1

Public Meeting on Patient Focused Drug Development for Idiopathic Pulmonary Fibrosis Part 1Подробнее

Public Meeting on Patient Focused Drug Development for Idiopathic Pulmonary Fibrosis Part 1

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 2Подробнее

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 2

Public Meeting on Patient Focused Drug Development for Alpha 1 Antitrypsin Part 2Подробнее

Public Meeting on Patient Focused Drug Development for Alpha 1 Antitrypsin Part 2

Public Meeting on Patient Focused Drug Development for Psoriasis Part 1Подробнее

Public Meeting on Patient Focused Drug Development for Psoriasis Part 1

Inborn Errors of Metabolism, Parents, and the FDAПодробнее

Inborn Errors of Metabolism, Parents, and the FDA

Public Meeting: Patient-Focused Drug Development for Opioid Use Disorder - Part 1Подробнее

Public Meeting: Patient-Focused Drug Development for Opioid Use Disorder - Part 1